Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00237042 · ClinicalTrials.gov registry record · NA
Managing Temporomandibular Disorder (TMD) Symptoms
A NA study of Temporomandibular Joint Disorders, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 252
- Enrollment target
- 1
- Study location
NCT00237042: Completed NA study of Temporomandibular Joint Disorders, sponsored by University of Washington.
NCT00237042 is a NA study of Temporomandibular Joint Disorders that has completed, run by University of Washington. The registered enrollment target is 252 participants, below the 373-participant average among 3 other Temporomandibular Joint Disorders trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00237042, a NA study of Temporomandibular Joint Disorders, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether treatments targeted to the hormonal factors and the cyclicity of TMD symptoms associated with the menstrual cycle are more effective in relieving TMD pain and symptoms than standard self management treatment.
Primary Outcome
Average of 0-10 ratings of current facial pain, average facial pain in the last month and worst facial pain in the last month, where 0 is no pain and 10 is pain as bad as could be. For the combined outcome, the minimum score is 0 and maximum is 10, with 0 being better (no pain) and 10 being the worst outcome.
Conditions Studied
Interventions
- BEHAVIORAL Self Management
- BEHAVIORAL Targeted Self Management
- DRUG 20 mcg ethinyl estradiol and 100 mcg levonorgestrel
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2005-10 |
| Est. Completion | 2010-06 |
| Phase | NA |
What the finished NCT00237042 record still lists
NCT00237042 is an interventional study that assigns participants to a tested intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, below the 373-participant average among 3 other Temporomandibular Joint Disorders trials with a reported enrollment target (32% lower).
The record links to 1 condition, with Temporomandibular Joint Disorders appearing as the primary indexed condition, and to 3 interventions - of which Self Management is the first listed.
NCT00237042 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT00237042 about?
NCT00237042 is a clinical study titled "Managing Temporomandibular Disorder (TMD) Symptoms". The purpose of this study is to determine whether treatments targeted to the hormonal factors and the cyclicity of TMD symptoms associated with the menstrual cycle are more effective in relieving TMD pain and symptoms than standard self management treatment.
What is the current status of trial NCT00237042?
This trial is currently completed. It is a NA study. The enrollment target is 252 participants. The study started on 2005-10. Estimated completion is 2010-06.
What conditions does trial NCT00237042 study?
This clinical trial studies the following conditions: Temporomandibular Joint Disorders.
What interventions are being tested in trial NCT00237042?
The interventions under investigation include: Self Management (BEHAVIORAL), Targeted Self Management (BEHAVIORAL), 20 mcg ethinyl estradiol and 100 mcg levonorgestrel (DRUG).
Who is sponsoring clinical trial NCT00237042?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00237042 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Temporomandibular Joint Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia